www.labonline.com.au Open in urlscan Pro
13.238.16.125  Public Scan

Form analysis
2 forms found in the DOM

POST /contents/results

<form class="form-inline" action="/contents/results" accept-charset="UTF-8" method="post"><input type="hidden" name="authenticity_token" value="RVzlGyNtxREfyxsdlKAWf57wTpGvosi0mwPtvM-SH2QhnmS4b7-tL8MkZNPaV6MR5e47uM0RAvko4Jp5XEkJug">
  <input type="text" name="query" id="query" value="" placeholder="Search..." class="form-control pull-left">
  <button class="btn btn-default pull-right glyphicon glyphicon-search red" type="submit"></button>
</form>

GET /contents/results

<form class="form-inline" action="/contents/results" accept-charset="UTF-8" method="get">
  <input type="text" name="query" id="query" value="" placeholder="Search..." class="form-control pull-left">
  <button class="btn btn-default pull-right glyphicon glyphicon-search red" type="submit"></button>
</form>

Text Content

CONTINUE TO SITE >>

 * Instrumentation
 * Equipment
 * Computing
 * Lab fit-out
 * R & D
 * Business


 * CONNECT

 * 
 * 
 * 
 * 

 * The Magazine
 * Events
 * Resources
 * Products
 * Business Directory
 * About Us
 * Life Scientist
 * Subscribe eNewsletter


CANNABIS EXTRACT FOUND TO SLOW MELANOMA CELL GROWTH


Friday, 23 February, 2024


--------------------------------------------------------------------------------

A cannabis extract has shown positive results in slowing down melanoma cell
growth and increasing cell death rates, according to an in vitro study published
in the journal Cells.

Researchers from Charles Darwin University (CDU) and RMIT University
investigated programmed cell death caused by a specific cannabis extract
(cannabinoid PHEC-66) from the Cannabis sativa plant. Their study found that the
extract binds to receptor sites on particular melanoma cells, then controls the
growth of cells at two pivotal phases and increases the amount of damage to the
cells. As explained by CDU pharmaceutical lecturer and co-author Dr Nazim
Nassar, this damage effectively manipulates the cell into killing itself.

“The damage to the melanoma cell prevents it from dividing into new cells, and
instead begins a programmed cell death, also known as apoptosis,” Nassar said.

“This is a growing area of important research because we need to understand
cannabis extracts as much as possible, especially their potential to function as
anticancer agents.

“If we know how they react to cancer cells, particularly in the cause of cell
death, we can refine treatment techniques to be more specific, responsive and
effective.”

Nassar said the next challenge will be developing a targeted delivery system to
the melanoma cells in preparation for preclinical trials. “Advanced delivery
systems still need to be fully developed, underscoring the importance of ongoing
efforts to ensure the proper and effective use of these agents at target sites,”
he said.



RMIT biotechnologist Professor Nitin Mantri, lead author on the study,
acknowledged the necessity for a long-term follow-up to ensure the sustained
effectiveness and safety of the PHEC-66 extract in cancer treatment over
extended periods, stressing the importance of testing the safety profile of the
extract before its widespread adoption.

“The subsequent stage involves animal studies or preclinical trials to validate
and further explore the efficacy of cannabinoid PHEC-66 in treating melanoma and
other cancers,” Mantri said.

He also highlighted the critical collaboration with Nassar, emphasising the need
for support and sponsorship from pharmaceutical companies to qualify PHEC-66 as
a registered medicine. This support is essential for advancing the development
and application of cannabis extracts in cancer treatment, leveraging Nassar’s
expertise as a healthcare professional, pharmacologist and pharmaceutical
scientist.

Nassar concluded that while the use of cannabis extracts to treat a variety of
health conditions is still stigmatised, further research into PHEC-66 could
revolutionise cancer treatment. “Intensive research into its potential for
killing melanoma cells is only the start as we investigate how this knowledge
can be applied to treating different types of cancers,” he said.

Image credit: iStock.com/Dolores Preciado

Related News

SPIDER SILK-INSPIRED ELECTRODE WRAPS AROUND TISSUES AND ORGANS

Scientists have created a flexible electrode that wraps around muscles, nerves
and hearts to...

WOMEN WITH HPV AT INCREASED RISK OF DEATH FROM HEART DISEASE

Women have a four times higher risk of dying from cardiovascular disease if they
have an...

STRESS INFLUENCES THE BRAIN VIA THE IMMUNE SYSTEM

Stress increases the migration of white blood cells called monocytes into the
vascular system of...

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

Featured Articles

Cyto-Facto Inc.: Advancing cell & gene therapies, providing the promise of
health



--------------------------------------------------------------------------------

Phasefocus Livecyte T-Cell Killing Assay tracks cancer cells and quantifies
T-cell interactions



--------------------------------------------------------------------------------

New Therapies: Bridge Knowledge, Speed and Quality



--------------------------------------------------------------------------------


Premium Listings


Resources
 * [eBook] The 21st century lab: your roadmap for transformation
   
   --------------------------------------------------------------------------------

 * How to ensure lab compliance and maximise your productivity
   
   --------------------------------------------------------------------------------

 * 3 critical factors of successfully deploying a single ELN in your lab
   
   --------------------------------------------------------------------------------

 * What you need to know at a glance
   
   --------------------------------------------------------------------------------

 * How to accelerate time to market in your research lab
   
   --------------------------------------------------------------------------------

Events
 * Cutting Edge Symposium Resilience in the Anthropocene
   
   --------------------------------------------------------------------------------

 * Pathology Update 2024
   
   --------------------------------------------------------------------------------

 * ASID 2024 Annual Scientific Meeting
   
   --------------------------------------------------------------------------------

 * World Science Festival Brisbane 2024
   
   --------------------------------------------------------------------------------

 * Science Meets Parliament 2024
   
   --------------------------------------------------------------------------------



--------------------------------------------------------------------------------


CONTENT FROM OTHER CHANNELS ON OUR NETWORK

Schneider Electric launches new program to support systems integrators

Rio Tinto signs Australia's biggest renewable power deal

Oracle adds new logistics capabilities to Oracle Cloud SCM

Is it a leak? Understanding the adiabatic process in pressure calibration

Rise in geopolitically driven OT cyber attacks in 2023: report

Steam injection meets demands of 'plant milk' producers

Enhancing fresh produce safety with edible wax technology

Food supply chain thefts rise in 2023

Drink mix capacity up 100% with bulk bag weigh batch discharging

Fonterra to merge its New Zealand and Australian businesses

Telstra Health partners with Smile Digital Health for interoperability

Virtus Health to deploy RingCentral in Australia, Europe

Lumia Care acquires nursing agency Healthcare HQ

Plasma treatment for healing chronic wounds

Medibank's Amplar signs US deal for prevention programs


ARE YOU INTERESTED IN JOINING ANY
OF OUR OTHER PROFESSIONAL CHANNELS?

 * Electrical, Comms & Data Contracting
 * Electronics Design & Engineering
 * Food Manufacturing & Technology
 * Laboratory Technology
 * Life Science & Biotechnology
 * Process Control & Automation
 * Radio Communications
 * Health & Safety at Work
 * Sustainability - Industry & government
 * IT Management
 * Hospital + Healthcare
 * GovTech Review
 * Aged Health



CONTACT INFORMATION

Westwick-Farrow Media
Locked Bag 2226
North Ryde BC NSW 1670
ABN: 22 152 305 336
www.wfmedia.com.au
Email Us


CONNECT WITH US


SUBSCRIBE TO LABONLINE

LabOnline has an editorial mix of business news, research and funding updates,
industry comment, feature articles, conference previews, case studies and
succinct new product items, making it a 'must read' for industry leaders.

SUBSCRIBE

Membership is FREE to qualified industry professionals across Australia.

For subscription enquiries please contact us
 * About Us
 * Contact Us
 * Advertising
 * RSS Feeds
 * Privacy
 * Terms
 * Sitemap

 * All content Copyright © 2024 Westwick-Farrow Pty Ltd